Naik, C., & Basu, S. Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndrome. Thieme Medical and Scientific Publishers Pvt. Ltd.
Chicago Style (17th ed.) CitationNaik, Chinna, and Sandip Basu. Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's Syndrome. Thieme Medical and Scientific Publishers Pvt. Ltd.
MLA (9th ed.) CitationNaik, Chinna, and Sandip Basu. Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's Syndrome. Thieme Medical and Scientific Publishers Pvt. Ltd.